Furthermore, in-depth analysis is required to clarify the molecular mechanisms by which lipid metabolism abnormalities regulate sepsis and AF through specific signaling pathways (e.g., NF-κB, p38 MAPK), evaluate the clinical translational value of feature genes and candidate drugs, and explore personalized treatment strategies based on lipid reprogramming. Here, NFKB1 is linked to atrial fibrillation.